secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enveric Biosciences, Inc. (ENVB)
CIK:        0000890821
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001493152-24-020489
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Enveric Biosciences receives Nasdaq delisting notice for bid price below $1.00
------------------------------------------------------------------------------

- Closing bid price below $1.00 for 30 consecutive business days as of May 16, 2024.
- Company has 180 days, until November 12, 2024, to regain compliance by closing at or above $1.00 for 10 consecutive days.
- If not compliant by deadline, may be eligible for additional 180 days if other listing standards met.
- Company considering available options, including potential reverse stock split, to cure deficiency.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/890821/000149315224020489/0001493152-24-020489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/890821/000149315224020489/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer